<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02056639</url>
  </required_header>
  <id_info>
    <org_study_id>819122</org_study_id>
    <nct_id>NCT02056639</nct_id>
  </id_info>
  <brief_title>Prevention of Preterm Birth With a Pessary in Twin Gestations</brief_title>
  <acronym>PoPPT</acronym>
  <official_title>Prevention of Preterm Birth With a Pessary in Twin Gestations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preterm birth (PTB) is a major health problem and contributes to more than 50% of the overall
      perinatal mortality. Twins are at increased risk for PTB. The number of twins births has
      risen substantially due to the increased use of assisted reproductive technology. The rate of
      twin births in the United States rose from 18.9 to 32.2 per 100 live births between 1980 and
      2004. The increased rate of PTB in twins is associated with increased morbidity and mortality
      rates. Almost one in four very low birth-weight infants (below 1500 g) born in the United
      States are twins, as are one in six infants who die in the first month of life. Cervical
      shortening is a risk factor for PTB. Transvaginal ultrasound measurement of cervical length
      is a reliable screening test for prediction of PTB. There is currently no effective treatment
      to decrease the incidence of PTB in women with twin gestations, but there is some evidence
      that the use of a cervical pessary in women with a short cervix has promise. If effective
      this approach would be particularly appealing because of the wide availability of pessaries,
      ease of use, and low cost. Unfortunately, existing studies are inadequate to confirm
      effectiveness; a well designed, properly powered, prospective randomized trial is warranted
      prior to widespread implementation in clinical practice. We propose such a trial to study the
      effectiveness of the pessary in decreasing the incidence of PTB in an inner city Philadelphia
      population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2014</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Preterm Delivery</measure>
    <time_frame>Less than 34 weeks gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Birth Weight of Babies in Each Group</measure>
    <time_frame>Time of delivery</time_frame>
    <description>The birth weight of babies is the pessary group and no pessary group were recorded and analyzed for comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous Preterm Birth Rates</measure>
    <time_frame>Less than 37 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants That Experienced Neonatal Death</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>Number of participants that experienced neonatal deaths that occurred in each group following birth was recorded and analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects Experiencing Chorioamnionitis</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Chorioamnionitis was recorded and analyzed for participants in each group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Premature Birth</condition>
  <condition>Short Cervix</condition>
  <arm_group>
    <arm_group_label>Pessary</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No pessary</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bioteque cup pessary</intervention_name>
    <arm_group_label>Pessary</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-50 years of age

          -  Twin pregnancy (limits the participants to female gender)

          -  Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at
             18-27 6/7 weeks gestation

        Exclusion Criteria:

          -  Singleton or higher order than twins multiple gestation

          -  Monoamniotic twins

          -  Twin twin transfusion syndrome

          -  Ruptured membranes

          -  Lethal fetal structural anomaly

          -  Fetal chromosomal abnormality

          -  Cerclage in place (or planned placement)

          -  Vaginal bleeding

          -  Suspicion of chorioamnionitis

          -  Ballooning of membranes outside the cervix into the vagina

          -  Painful regular uterine contractions

          -  Labor

          -  Placenta previa
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorraine Dugoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincenzo Berghella</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jack Ludmir</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2014</study_first_submitted>
  <study_first_submitted_qc>February 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2014</study_first_posted>
  <results_first_submitted>October 24, 2017</results_first_submitted>
  <results_first_submitted_qc>April 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 28, 2018</results_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Premature birth</keyword>
  <keyword>Premature delivery</keyword>
  <keyword>Short cervix</keyword>
  <keyword>Pessary</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pessary</title>
          <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
        </group>
        <group group_id="P2">
          <title>No Pessary</title>
          <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pessary</title>
          <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
        </group>
        <group group_id="B2">
          <title>No Pessary</title>
          <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="46"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Preterm Delivery</title>
        <time_frame>Less than 34 weeks gestation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
          </group>
          <group group_id="O2">
            <title>No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Preterm Delivery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Birth Weight of Babies in Each Group</title>
        <description>The birth weight of babies is the pessary group and no pessary group were recorded and analyzed for comparison.</description>
        <time_frame>Time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>A biotec. pessary will be placed in subjects.</description>
          </group>
          <group group_id="O2">
            <title>No Pessary</title>
            <description>No pressary will be inserted and subjects will follow standard of care.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Birth Weight of Babies in Each Group</title>
          <description>The birth weight of babies is the pessary group and no pessary group were recorded and analyzed for comparison.</description>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2190" lower_limit="1115" upper_limit="2540"/>
                    <measurement group_id="O2" value="2220" lower_limit="1864" upper_limit="2583"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spontaneous Preterm Birth Rates</title>
        <time_frame>Less than 37 weeks gestation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
          </group>
          <group group_id="O2">
            <title>No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
          </group>
        </group_list>
        <measure>
          <title>Spontaneous Preterm Birth Rates</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants That Experienced Neonatal Death</title>
        <description>Number of participants that experienced neonatal deaths that occurred in each group following birth was recorded and analyzed.</description>
        <time_frame>Between birth and 28 days of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
          </group>
          <group group_id="O2">
            <title>No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants That Experienced Neonatal Death</title>
          <description>Number of participants that experienced neonatal deaths that occurred in each group following birth was recorded and analyzed.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects Experiencing Chorioamnionitis</title>
        <description>Chorioamnionitis was recorded and analyzed for participants in each group.</description>
        <time_frame>Time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pessary</title>
            <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
          </group>
          <group group_id="O2">
            <title>No Pessary</title>
            <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects Experiencing Chorioamnionitis</title>
          <description>Chorioamnionitis was recorded and analyzed for participants in each group.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Pessary</title>
          <description>Use of the Bioteque cup pessary. Pessary will be placed between 18 and 27 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
Bioteque cup pessary</description>
        </group>
        <group group_id="E2">
          <title>No Pessary</title>
          <description>No pessary will be used. Subjects will receive standard obstetrical management</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>UTI</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The main limitation of our study was the fact that it was stopped before planned enrollment was complete, which resulted in a small sample size.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Bridget Nolan</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>2156623324</phone>
      <email>bridget.nolan@uphs.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

